Warning letter
Nature's Sunshine Products, Inc.: warning letter of Jun 19, 2001
FDA warning letter UCM178424 · Denver District Office
Key facts
| Reference number | UCM178424 |
|---|---|
| Company | Nature's Sunshine Products, Inc. |
| Subject | Lovastatin/Red Yeast Rice Product/Lacks Approved New Drug Application |
| Issue date | Jun 19, 2001 |
| Posted date | Jun 19, 2001 |
| Issuing office | Denver District Office |
| Product type | Drugs |
| Country | 3 |
| Inspection city | Spanish Fork |
| Inspection ZIP | 84660-1010 |
| Inspection start date | Feb 6, 2001 |
| Letter on fda.gov | web.archive.org |
At a glance
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: